Follow-up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin-free treatment

Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis

(2017) Sujan Ravi et al.   GASTROENTEROLOGY

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications

(2017) Pierre Nahon et al.   GASTROENTEROLOGY

Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents

(2017) Fasiha Kanwal et al.   GASTROENTEROLOGY

Comments on cochrane review on direct-acting antivirals for hepatitis C

(2017) Anna S. Lok et al.   HEPATOLOGY

Optimal timing of hepatitis C treatment for patients on the liver transplant waiting list

(2017) Jagpreet Chhatwal et al.   HEPATOLOGY

Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry

(2017) Carlos Fernández Carrillo et al.   HEPATOLOGY

Degree of liver fibrosis regression predicted by transient elastography after cure of chronic hepatitis C with direct acting antivirals is overestimated but confirmed by liver biopsy

(2017) P. Pockros et al.   JOURNAL OF HEPATOLOGY

Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication

(2017) Adriaan J. van der Meer et al.   JOURNAL OF HEPATOLOGY

Mortality in hepatitis C patients who achieve a sustained viral response compared to the general population

(2017) Hamish Innes et al.   JOURNAL OF HEPATOLOGY

Letter: retreatment of patients with chronic hepatitis C who have failed interferon-free combination therapy with direct acting anti-virals

(2016) K. Kozbial et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Adding ribavirin to newer DAA regimens does not affect SVR rates in HCV genotype 1 infected persons: results from ERCHIVES

(2016) A. A. Butt et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort

(2016) Tania M Welzel et al.   GUT

Hepatocellular carcinoma and direct acting antiviral treatments: Controversy after the revolution

(2016) Jean-Charles Nault et al.   JOURNAL OF HEPATOLOGY

Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals

(2016) Fabio Conti et al.   JOURNAL OF HEPATOLOGY

Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study

(2016) Luca Saverio Belli et al.   JOURNAL OF HEPATOLOGY

High incidence of hepatocellular carcinoma following successful interferon-free antiviral therapy for hepatitis C associated cirrhosis

(2016) Helder Cardoso et al.   JOURNAL OF HEPATOLOGY

Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatment

(2016) Karin Kozbial et al.   JOURNAL OF HEPATOLOGY

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy

(2016) María Reig et al.   JOURNAL OF HEPATOLOGY

Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis

(2016) Michelle C.M. Cheung et al.   JOURNAL OF HEPATOLOGY

Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts

(2016)   JOURNAL OF HEPATOLOGY

Regression of fibrosis and portal hypertension in HCV-associated cirrhosis and sustained virologic response after interferon-free antiviral therapy

(2016) V. Knop et al.   JOURNAL OF VIRAL HEPATITIS

Effect of HCV clearance with direct-acting antiviral agents on HCC

(2016) Josep M. Llovet et al.   Nature Reviews Gastroenterology & Hepatology

Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon

(2016) Roberta D’Ambrosio et al.   PLoS One

Successful anti-viral treatment improves survival of patients with advanced liver disease due to chronic hepatitis C

(2015) K. Rutter et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A pleasant dilemma to have: to treat the HCV patient on the waiting list or to treat post-liver transplantation?

(2015) Jonathan E. Barsa et al.   CLINICAL TRANSPLANTATION

HCV targeting of patients with cirrhosis

(2015) Peter Ferenci et al.   JOURNAL OF HEPATOLOGY

Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis

(2013) Adriaan J. van der Meer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis

(2012) Roberta D'Ambrosio et al.   HEPATOLOGY

A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin

(2010) Mark G. Swain et al.   GASTROENTEROLOGY

A Sustained Viral Response Is Associated With Reduced Liver-Related Morbidity and Mortality in Patients With Hepatitis C Virus

(2009) Amit G. Singal et al.   Clinical Gastroenterology and Hepatology

Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patients

(2008) Sarah L. George et al.   HEPATOLOGY